DiaMedica Therapeutics Inc.
DMAC
Health Care
2
exclusion reasons
1 theme
DiaMedica Therapeutics Inc. is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
DiaMedica Therapeutics Inc. is a biotechnology company whose research and development activities involve animal testing. The company's preclinical studies, which are standard in the pharmaceutical industry, utilize animal models to assess the safety and efficacy of its therapeutic candidates. This places its operations within the commercial exploitation of animals for research purposes.
Specific details regarding the scale, species involved, or internal animal welfare policies are not currently documented in the exclusion record. Further evidence gathering from regulatory filings, scientific publications, or direct company disclosures is required to substantiate the scope of this activity.
DiaMedica Therapeutics is a clinical-stage biopharmaceutical company whose lead drug candidate, DM199, is a recombinant form of human tissue kallikrein 1 (KLK1) being developed for acute ischemic stroke and chronic kidney disease. The company’s drug development pipeline is built on preclinical research involving animal studies. Its SEC filings routinely cite “preclinical laboratory tests, animal studies and formulation studies” as part of its research and development process for DM199 and other candidates. As a pharmaceutical company seeking regulatory approval for novel biologic therapies, DiaMedica’s research model inherently relies on animal testing to demonstrate safety and efficacy.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.